| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Toxicity/Toxicokinetics |
Interactions
Repeated subcutaneous injections of 2-octanone alone did not affect the conduction velocity of motor and sensory fibers in the rat tail; however, combined injection of 2-octanone with methyl n-butyl ketone (MnBK) significantly enhanced the neurotoxicity observed with MnBK alone. This study investigated the effects of non-toxic aliphatic ketones on the neurotoxicity of methyl n-butyl ketone. Male Donryu rats were exposed to methyl n-butyl ketone (alone) or methyl n-butyl ketone (in combination with methyl ethyl ketone, methyl n-propyl ketone, methyl n-pentyl ketone, or methyl n-hexyl ketone). Each ketone compound was administered subcutaneously at an equimolar dose (4 mmol/kg) once daily, five days a week, for 20 weeks. Animal weight was measured every two weeks, and neurotoxicity symptoms were observed. Maximum motor fiber conduction velocity and distal latency of the tail nerve were measured every two weeks. All test animals showed a significant decrease in body weight compared to the control group. Animals treated with methyl n-butyl ketone (MnBJ) alone experienced more significant weight loss than those treated with MnBJ, MnBJ, MnBJ, and MnBJ. Hind limb weakness was observed in the test animals. Rats treated with multiple ketone compounds in combination showed more severe hind limb weakness compared to rats treated with MnBJ alone. All ketone compounds enhanced the neurotoxicity of MnBJ, manifested as decreased conduction velocity of tail nerve motor fibers and prolonged distal latency. MnBJ showed the most significant enhancing effect on MnBJ. The authors noted that MnBJ has the longest carbon chain. They suggest that the carbon chain length of aliphatic ketones is directly related to their ability to enhance the neurotoxicity of MnBJ. Non-Human Toxicity Values Oral LD50 in rats: 9 mg/kg (data from table) Oral LD50 in rats: >5 g/kg Intraperitoneal LD50 in rats: 800 mg/kg Oral LD50 in mice: 1.6 g/kg Intraperitoneal LD50 in mice: 1600 mg/kg Toxicity Data LC50 (rat) > 2,132 ppm/6 hours |
|---|---|
| Additional Infomation |
2-Octanone is a methyl ketone, a compound in which octane is replaced by a carbonyl group at the 2-position. It is a metabolite. 2-Octanone has been reported to exist in plants of the genus *Heracleum dissectum*, *Eryngium foetidum*, and other organisms with relevant data.
|
| Molecular Formula |
C8H16O
|
|---|---|
| Molecular Weight |
128.21
|
| Exact Mass |
128.12
|
| CAS # |
111-13-7
|
| PubChem CID |
8093
|
| Appearance |
Colorless to light yellow liquid
|
| Density |
0.8±0.1 g/cm3
|
| Boiling Point |
173.1±3.0 °C at 760 mmHg
|
| Melting Point |
-16 °C
; Liquid Molar Volume = 0.157391 cu m/kmol; IG Heat of Formation = -3.2160X10+8 J/kmol; Heat of Fusion at melting point = 2.4419X10+7 J/kmol
; -16 °C
; -16 °C
|
| Flash Point |
62.8±0.0 °C
|
| Vapour Pressure |
1.7±0.3 mmHg at 25°C
|
| Index of Refraction |
1.411
|
| Source |
Originated from animals: 河狸Castor
|
| LogP |
2.5
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
9
|
| Complexity |
76.6
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
|
| InChi Key |
ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C8H16O/c1-3-4-5-6-7-8(2)9/h3-7H2,1-2H3
|
| Chemical Name |
octan-2-one
|
| Synonyms |
Hexyl methyl ketone
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (19.50 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 400 μL of PEG300 and mix well; then add 50 μL of Tween-80 and mix well; finally add 450 μL of physiological saline and adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (19.50 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: 2.5 mg/mL (19.50 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Suspended solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.7997 mL | 38.9985 mL | 77.9970 mL | |
| 5 mM | 1.5599 mL | 7.7997 mL | 15.5994 mL | |
| 10 mM | 0.7800 mL | 3.8999 mL | 7.7997 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
